Qualitative evaluation of the cancer cells within each tumour core showed that gastric carcinomas generally had moderate (25–75%) to high (>75%) percentage of CD133+ while pancreatic and hepatocellular/cholangiocarcinomas cases have generally low (<25%) to moderate % CD133+ tumour cells with some rare high percentage cases. The gene discussed is PROM1; the disease is neoplasm.